Media Centre
Latest press releases
-
AstraZeneca and MSD rapidly advance Lynparza in Japan with a second regulatory submission
-
US FDA approves new easy-to-use, once-weekly Bydureon BCise injectable medicine for patients with type-2 diabetes
-
US FDA accepts regulatory submission for Lynparza in metastatic breast cancer and grants Priority Review
-
US FDA accepts supplemental Biologics License Application for Imfinzi in locally advanced unresectable non-small cell lung cancer
-
AstraZeneca shares its comprehensive scientific approach at the World Conference on Lung Cancer 2017
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Esra Erkal-Paler
Global Head of External Communications
Karen Birmingham
Director Global Science Media
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Gonzalo Viña
Director Global Media Relations
Jacob Lund
Director External Communications, Sweden
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
